CD36 and Hyperglycemia: The inhibition of CD36 reduces hyperglycemia-induced ROS production, activation of the ERK1/2 and Smad2 signaling pathway, and expression of prosclerotic cytokine TGF-β1 and ECM protein fibronectin [203].